Dexcom (Nasdaq:DXCM) today announced plans to unveil its Smart Basal integrated titration module for insulin delivery.

The FDA identified a recall of smartphone apps for Dexcom (Nasdaq:DXCM) continuous glucose monitors as the most serious type.

Insulet (Nasdaq:PODD) has its eyes on future expansion in new geographies, according to some of its leading executives.

Elutia announced today that it agreed to sell its bioenvelope technologies to Boston Scientific for $88 million.

Johnson & Johnson announced today that the FDA approved Inlexzo, its gemcitabine intravesical drug delivery system.

The NHS announced a first-of-its-kind initiative in England, offering automated insulin delivery systems for pregnant women ...

Dexcom (Nasdaq:DXCM) filed with the state of California to confirm plans to lay off more than 300 employees in San Diego.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that Health Canada authorized its t:slim mobile application for Android ...

Utrecht, The Netherlands-based ViCentra plans to use the funds to accelerate manufacturing scale, launch its next-generation ...

Senseonics announced that it entered into an agreement with Diabetes Care to take over commercialization efforts for its ...

Orange Biomed announced a major milestone on its path to bringing a pocket-sized A1C analysis device to the market.

Ypsomed announced that the FDA granted 510(k) clearance for SmartPilot, a digital connectivity add-on for its Ypsomate ...